ELVN
Enliven Therapeutics, Inc.
$50.92
+0.91 (+1.82%)
At close · Jul 7
Market Cap
$3.10B
Shares
60,904,946
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$103.69M
-16.5%
FY2025
Diluted EPS
-$1.83
+3.2%
FY2025
Operating Cash Flow
-$70.3M
+3.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $81.65M | $85.86M | $80.78M | $64.57M | $18.94M | $38.44M | $32.15M | |
| $34.14M | $33.8M | $23.78M | $18.96M | $15.33M | $13M | $9.54M | |
| $240K | $300K | $300K | $300K | — | — | — | |
| $115.79M | $119.66M | $104.55M | $83.53M | $34.27M | $51.44M | $41.7M | |
| -$115.79M | -$119.66M | -$104.55M | -$83.53M | $730K | -$51.44M | -$41.7M | |
| $17.01M | $15.96M | $15.53M | $11.95M | $846K | $58K | $338K | |
| — | — | — | — | $1.58M | — | — | |
| — | $0 | $232K | $0 | $88K | — | — | |
| -$98.78M | -$103.69M | -$89.02M | -$71.58M | $1.49M | -$51.38M | -$41.36M | |
| -$99.14M | -$103.42M | -$89.11M | -$71.44M | $1.5M | -$51.4M | -$41.39M | |
| USD/shares | — | -$1.83 | -$1.89 | -$2.01 | $0.06 | — | — |
| USD/shares | — | -$1.83 | -$1.89 | -$2.01 | $0.06 | — | — |
| shares | — | 56.66M | 47.07M | 35.55M | 26.29M | 21.66M | 13.92M |
| shares | — | 56.66M | 47.07M | 35.55M | 26.39M | 21.66M | 13.92M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.